LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Medlab Middle East Rebranded to WHX Labs Dubai

By LabMedica International staff writers
Posted on 06 Feb 2025
Print article
Image: The unveiling of WHX Labs Dubai marks a new era for laboratory innovation (Photo courtesy of Informa Markets)
Image: The unveiling of WHX Labs Dubai marks a new era for laboratory innovation (Photo courtesy of Informa Markets)

Informa Markets (London, UK) has officially announced the rebranding of Medlab Middle East to WHX Labs Dubai, underscoring a transformative vision for connecting people, businesses, governments and innovators across borders. The name World Health Expo (WHX) unifies Informa’s healthcare events around the world to better facilitate connection and collaboration under a single brand.

Medlab Middle East 2025, held at the Dubai World Trade Centre (DWTC) under the theme ‘Empowering today’s medical labs for tomorrow’s future,’ brought together over 800 exhibitors and welcomed more than 20,000 visitors to explore the latest technology and updates for the laboratory industry. The event is showcasing the latest innovations and technologies across eight dynamic product categories, which include Disposables and Consumer Goods, Emergency Medicine, Imaging and Diagnostics, Healthcare and General Services, IT, Laboratory, Medical Equipment and Devices and Pharma and Nutrition. WHX Labs Dubai will build on Medlab Middle East’s 24 years of success, connecting more than half a million healthcare professionals in nine countries across four continents. By consolidating each event within the Informa Markets Healthcare portfolio, WHX aims to amplify their impact, fostering greater innovation, stronger connections and transformative progress within the healthcare ecosystem.

“WHX Labs Dubai represents the evolution of the laboratory industry into a global force for scientific advancement – an exciting future driven by international collaboration, technological breakthroughs, and innovation from around the world,” said Tom Coleman, Group Exhibition Director, Informa Markets Healthcare. “This new identity highlights Dubai’s essential role as a hub for laboratory innovation and reinforces the city’s lasting impact on the industry’s advancement. By establishing WHX Labs Dubai, we reaffirm our commitment to driving progress in the sector while honoring Dubai’s dynamic ecosystem, which continues to foster cutting-edge scientific discovery and development.”

Related Links:
Informa Markets

Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Immunofluorescence Analyzer
MPQuanti
New
Auto Clinical Chemistry Analyzer
cobas c 703

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.